Drug ID: | NPD6971 |
Drug Name: | CLX-0921 |
Molecular Formula: | C28H25NO7S |
Canonical SMILES: | COC(=O)/C(=C/c1cc(OC)cc(c1)OC)/c1ccc(cc1)Oc1ccc(cc1)CC1SC(=O)N=C1O |
Standard InCHI: | InChI=1S/C28H25NO7S/c1-33-22-12-18(13-23(16-22)34-2)14-24(27(31)35-3)19-6-10-21(11-7-19)36-20-8-4-17(5-9-20)15-25-26(30)29-28(32)37-25/h4-14,16,25H,15H2,1-3H3,(H,29,30,32)/b24-14+ |
Standard InCHIKey: | IVAQJHSXBVHUQT-ZVHZXABRSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB013516 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 519.14 |
ALogP | 0.1887 |
MLogP | 3.55 |
XLogP | 5.911 |
HDA | 5 |
HBD | 1 |
Rotatable Bonds | 14 |
TPSA | 128.95 |
RO5 Violation | 1 |